Figure 9. Expression level of CCND2, COL3A1, COL4A1, RAC2, and HCP5 in GSE48944 and GSE47184 in controls and in chronic kidney disease (CKD) patients. *P<0.05; **P<0.01; ***P<0.005. x indicates not significant. Statistical analyses were performed with the t-test.